For the Treatment of Moderate to Severe Alzheimer's Disease, a Combination Treatment That Delays Nursing Home Admission Would Earn Higher Patient Share in the U.S. Than Europe

Wednesday, February 17, 2010 General News
Email Print This Page Comment
Font : A-A+

The Dimebon Plus Aricept Combination Will Become Decision Resources' Proprietary Clinical Gold Standard for the Treatment of Moderate to Severe Alzheimer's Disease in 2013

For more information, contact:

Gisselle Morales

Elizabeth Marshall

Decision Resources

Decision Resources, Inc.

781-296-2691

781-296-2563

gmorales@dresources.com

emarshall@dresources.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook